Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0VO7R
|
|||
| Former ID |
DNC000172
|
|||
| Drug Name |
AjvW2
|
|||
| Synonyms |
2,6-Piperazinedione, 4,4'-(1,2-dimethyl-1,2-ethanediyl)bis-, rel-; Icrf 193; ICRF-193; 21416-88-6; BRN 3981691; 2,6-Piperazinedione, 4,4'-(1,2-dimethylethylene)di-, meso-; 2,6-Piperazinedione, 4,4'-(1,2-dimethyl-1,2-ethanediyl)bis-, (R*,S*)-; AC1L3O6B; meso-2,3-Bis(3,5-dioxopiperazine-1-yl)butane; KBioSS_000487; BSPBio_001147; KBioGR_000487; SCHEMBL438498; CHEMBL264684; KBio3_000893; KBio3_000894; KBio2_003055; CHEBI:93771; KBio2_000487; KBio2_005623; HMS1990I09; HMS1792I09; Bio2_000884; HMS3403I09; Bio2_000404; HMS1362I09; ICRF
Click to Show/Hide
|
|||
| Drug Type |
Antibody
|
|||
| Indication | Thrombosis [ICD-11: DB61-GB90; ICD-10: I80-I82] | Phase 1 | [1] | |
| PubChem Substance ID |
10238334, 11121749, 11122229, 11362901, 11365463, 11368025, 11370993, 11370994, 11373626, 11376187, 14750955, 24896062, 26756840, 26756841, 29300050, 48169020, 48393605, 50012867, 50111449, 57339319, 75114731, 92310100, 99301012, 99302532, 103567119, 104407504, 128786916, 134339682, 134340112, 135073849, 141868838, 162248102, 226761503, 241039874, 252455824
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800009728) | |||
| REF 2 | The catalytic DNA topoisomerase II inhibitor ICRF-193 and all-trans retinoic acid cooperatively induce granulocytic differentiation of acute promyelocytic leukemia cells: candidate drugs for chemo-differentiation therapy against acute promyelocytic leukemia. Exp Hematol. 2002 Nov;30(11):1273-82. | |||
| REF 3 | Novel approaches to the treatment of thrombosis. Trends Pharmacol Sci. 2002 Jan;23(1):25-32. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.